The role of erythropoietin (Epo) in angiogenesis has not been completely clarified. Epo induces endothelial cell proliferation and migration and stimulates angiogenesis on rat aortic rings in vitro and in vivo in the chick embryo chorioallantoic membrane (CAM) assay. The aim of the present study was to evaluate the ultrastructural aspects of angiogenesis in the CAM vasculature after recombinant human Epo (rHuEpo) exposure. The results demonstrated that after rHuEpo stimulation, the generation of new blood vessels occurred more frequently following an intussusceptive microvascular growth (IMG) mechanism. We have performed our experiments between days 8 and 12 of incubation, that is, when in the normal condition the capillary network expands mainly by IMG, and because it is generally accepted that implants made from days 8 to 10 are strongly angiogenic. This response is peculiar of rHuEpo, because it is abolished when an Epo-blocking antibody was coadministered with Epo.
Introduction
Angiogenesis, the process through which new blood vessels arise from pre-existing ones, is a focus of attention for many scientists from various fields. It is involved during embryonal development and later, in adult life, in several physiological and pathological conditions in which angiogenesis itself contributes to the progression of disease. 1 There are at least two types of angiogenesis: (a) the so-called 'sprouting' angiogenesis, which is characterized by the proliferation and migration of endothelial cells into avascular sites; 2 (b) the 'nonsprouting' angiogenesis or intussusceptive microvascular growth (IMG), which occurs by splitting of the existing vasculature by transluminal pillars or transendothelial bridges. 3 In contrast to sprouting angiogenesis, which is a wellestablished mode of new blood vessel formation, IMG is a relatively new concept in vascular biology. It was first described in the lung, 4 in the myocardium, 5 in the chick embryo chorioallantoic membrane (CAM) 6 and in a variety of other rat organs. 7 Furthermore, IGM have been detected during angiogenesis in solid and hematological tumors. 8, 9 The role of erythropoietin (Epo) in angiogenesis has not been completely clarified. 10 Endothelial cells from some sources express Epo receptor (EpoR). 11 Moreover, Epo induces endothelial cell proliferation and migration [11] [12] [13] [14] and has been shown to stimulate angiogenesis on rat aortic rings in vitro 15 and in vivo in the CAM assay. 13 The aim of the present study was to evaluate the ultrastructural aspects of angiogenesis in the CAM vasculature after recombinant human Epo (rHuEpo) exposure.
Materials and methods
Fertilized White Leghorn chick eggs were incubated under conditions of constant humidity at 371C. On the third day of incubation, a square window was opened in the egg shell after the removal of 2-3 ml of albumen so as to detach the developing CAM from the shell. The window was sealed with a glass of the same size, and the eggs were returned to the incubator. The experiments were performed between days 8 and 12 of incubation, because it is generally accepted that implants made from days 8 to 10 are strongly angiogenic. 16 This finding might depend on the fact that the CAM endothelium exhibits an intrinsically high mitotic rate until day 10. 17 Thereafter, the mitotic index declines rapidly and the vascular system attains its final arrangement on day 18, just before hatching. 17 Moreover, between days 8 and 12 of incubation, the CAM capillary network expands mainly by IMG. 18 At day 8, 1 mm 3 sterilized gelatin sponges (Gelfoam; Upjohn Co., Kalamazoo, MI, USA) dissolved in 2 ml of PBS were implanted on the top of growing CAM under sterile conditions within a laminar flow hood. 19 RHuEpo (Eprex; Janseen-Cilag, Cologno Monzese, Milan, Italy) was delivered at 1.0-10.0 U/implant, whereas sponges containing 500 ng of FGF-2 (R & D Systems, Abingdon, UK) or vehicle alone were used as positive or negative controls, respectively. In some experiments, rHuEpo was added in the presence of 200 ng/implant of a polyclonal-goat anti-human-Epo antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). At day 12, CAM were processed for electron microscopy. Briefly, the embryos and their membranes were fixed in ovo in 3% phosphate-buffered glutaraldehyde for 3 h. Approximately 1 mm 3 CAM's specimens were washed in the same buffer for 12 h, postfixed in 1% phosphate-buffered osmium tetroxide, dehydrated in graded ethanol series and embedded in Epon 812. Ultrathin sections were cut with a diamond knife on an LKB V ultramicrotome (LKB, Bromma, Sweden) according to a plane parallel to the surface of the CAM. The sections were stained with uranyl acetate followed by lead citrate and examined under a Philips CM 12 electron microscopy.
At day 12, some CAMs were also processed for immunohistochemistry. The antibody used in this study was a polyclonal rabbit anti-EpoR antibody (Santa Cruz Biotechnology). Acetonefixed cryostat CAM sections (8 mm), treated with 7.5% H 2 O 2 to destroy endogenous peroxidase, were stained with a three-step avidin-biotin immunoperoxidase, as described elsewhere. 20 Briefly, incubation with primary antibody and then biotinlabeled swine antirabbit IgG (Dako, Glostrup, Denmark) and avidin-horseradish peroxidase conjugate (Vector Inc., Burlingame, CA, USA) was followed by red staining with a 3-amino-9-ethylcarbazole (Sigma Chemical Co., St Louis, MO, USA) solution and counterstained with Gill's hematoxylin no. 2 (Polysciences Inc., Washington, PA, USA) and was mounted in buffered glycerine. A preimmune rabbit serum (Dako) replacing the primary antibody that served as a negative control.
Morphometric evaluation of different morphological patterns of CAM blood vessels
In all, 200 electron micrographs (100 for the control and 100 for the experimental series, respectively) at a final magnification of Â 3000 were chosen. The morphological structural changes were categorized as follows: the sprout formation, pillar formation by folding of the lateral vascular wall, fusion of pillars and connection of intraluminal tissue folds with the opposite vascular wall. The total number of vessels, the number of vessels categorized as specified previously, were counted with the use of an electronic pen connected to a graphic tablet (Digicad Plus Kontron-Elektronic, GMBH, Germany) and to a VIDAS 2.5 computerized image analyzer (Kontron Elektronic). The mean value in each case, the final mean value for all cases and the standard deviation were calculated for each variable. The statistical significance of the difference between the mean values of all the variables examined was determined by Student's t-test for unpaired data The final values were expressed as the percentage of the total number of vessels.
Results
On day 12 of incubation, macroscopic observation of the CAM treated with rHuEpo showed an angiogenic response characterized by the presence of allantoic vessels spreading radially towards the sponge in a spoked wheel pattern ( Figure 1a ). The effect was dose dependent, with the number of positive implants (of a total of 10 embryos per group) being equal to 0, 2, 3, 8 and 9 implants for 1.0, 2.0, 5.0, 10.0 and 20 U of rHuEpo per sponge, respectively. A similar macroscopic angiogenic response was observed in nine of 10 implants treated with 500 ng of FGF-2 (data not shown), whereas no vascular reaction was detectable around the sponge in the 10 specimens treated with vehicle alone (data not shown). When an Epo-blocking antibody was coadministered with Epo, no vascular reaction was detectable around the sponge (Figure 1b ). The capacity of rHuEpo to exert an angiogenic response in the CAM prompted us to assess this tissue for the presence of EpoR. As shown in Figure 1c , a marked immunoreactivity to anti-EpoR antibody was observed in the vascular endothelium of the CAM of untreated embryos starting from day 8 of incubation.
Transmission electron micrographs of sections running parallel to the CAM surface from the mesenchymal base to the chorionic top revealed the morphological features of the newly formed blood vessels in the CAM on day 12, in the control and experimental series.
In the controls, CAM is characterized by the presence of a chorionic epithelium composed of two layers of cells separated from the underlying capillary plexus by a very thin basement membrane. Some capillaries merging from the larger vessels scattered in the mesoderm were located beneath the chorion to form a primitive capillary plexus. The adjacent endothelial cells, which constitute the capillary plexus, showing an abundance of free ribosomes and rough endoplasmic reticulum, are closely apposed and sometimes overlapped for a short distance and are subtended by a discontinuous basement membrane (Figure 2 ). Morphometric evaluation revealed that the sprout formation represented the peculiar modality of angiogenic response taking place in the CAM vasculature in the normal condition, while IMG occurred in some instances (Table 1) .
In the experimental specimens, 4 days after the stimulation with rHuEpo, numerous aggregations of poorly differentiated endothelial cells were observed to be scattered in the stroma and located either close to the capillary plexus or far from vascular structures (Figure 3 ). Endothelial cells showed extremely irregular surface profiles, an oval nucleus with peripherally condensed chromatin and numerous free ribosomes and coated vesicles in their cytoplasm (Figure 3) . Their surface processes were thin and elongated or short and blunt, and interdigitated with similar cytoplasmic processes of neighboring cells (Figure 3) . Basement membrane constituents were not recognizable. The end result was the formation of complex labyrinthic clefts between cell and cell ( Figures 3  and 4) .
In some instances, newly formed blood vessels were in close topographic continuity with the parental vessel and originated by a sprouting mechanism from pre-existing vascular structures (Figures 4 and 5 and Table 1 ). In these cases, solid cords of IMG induced by rHuEpo in vivo E Crivellato et al endothelial cells originated from the vascular wall and penetrated deeply into the surrounding stroma, generating new vascular side branches. In the sprouting segment, a very narrow slit-like lumen, sealed by junctional complexes, was recognizable ( Figures 4 and 5) . The sprouting vessels were also enveloped by thin layers of fibroblast-like stromal cells, closely apposed to the endothelium (Figure 4 ). More frequently, generation of new blood vessels occurred following an IMG mechanism and was accomplished by a process of longitudinal segmentation of pre-existing blood vessels (Table 1) . We have identified three morphological structural changes in terms of the expression of IMG: pillar formation by folding of the lateral vascular wall, fusion of pillars and connection of intraluminal tissue folds with the opposite vascular wall. Sometimes, we observed a process of progressive longitudinal invagination along the opposite sites of the vascular wall, expression of a pillar formation (Figures 5 and 6 ). The perivascular stroma penetrated deeply into the lumen, pushing the endothelial lining inside, and two distinct new vessels finally originate by the division of the primitive vessel, according to IMG mode (Figures 5 and 6) . In other instances, a single endothelial cell connected the opposite walls of a pre-existing vessel, like a transluminal bridge, expression of the connection of intraluminal tissue folds with the opposite vascular wall (Figure 6 ). This process caused the splitting of the original vascular structure into two newly formed blood vessels.
Finally, these different angiogenic mechanisms led to the formation of a great number of well-structured capillaries ( Figure 7) . These vessels presented a continuous endothelial cell lining, sealed by junctional complexes at the sites of cell-tocell contact. Well-differentiated endothelial cells exhibited irregular surface profiles with numerous cytoplasmic protrusions abutting into the vascular lumen. Their cytoplasm contained a few mitochondria, vacuoles of different dimensions and electron density, free ribosomes and coated vesicles. The areas of contact between adjacent endothelial cells presented a complex pattern of interdigitation. A capillary from a 12-day-old control CAM. The endothelial cells exhibit an abundance of free ribosomes, and a rough endoplasmic reticulum and a few pinocytotic vesicles are recognizable. Bar ¼ 2 mm.
Figure 3
Electron micrographs of CAM samples treated with rHuEpo. In (a), an area of intense angiogenesis characterized by a cluster of poorly differentiated cells, exhibiting highly irregular surface profiles and cytoplasmic processes closely interdigitating with similar projections of neighboring cells. In (b), cells undergoing differentiation toward endothelial cells exhibit thin delicate or blunt, highly convoluted surface processes. The cytoplasm is rich in free ribosomes and coated vesicles (see inset). Bar: a ¼ 2 mm; b ¼ 0.6 mm (inset ¼ 0.25 mm). Table 1 Morphometric evaluation of different morphological patterns of CAM blood vessels expressed as the percentage of the total number of estimated vessels 
Discussion

Epo may be considered as an angiogenic factor
EpoR mRNA is expressed in endothelial cells of human umbilical vein endothelial cells (HUVECs), 11 bovine adrenal capillaries 12 and rat brain capillaries. 21 Epo stimulates the proliferation and migration of cultured HUVEC, 13 of human and bovine endothelial cells in vitro 12,21, as well as microvascular endothelial cells isolated from rat mesentery 14 and in the rat aortic ring model. 15 We have demonstrated that rHuEpo induces a proangiogenic phenotype in human endothelial cells. 13 This phenotype included both early (ie increase in cell proliferation and matrix metalloproteinase-2 production) and late (differentiation into vascular tubes) angiogenic events. Accordingly, endothelial cells expressed EpoR that bound JAK2 and included its transient activation after rHuEpo exposure. More recently, Jaquet et al. 22 investigated the angiogenic potential of rHuEpo on endothelial cells derived from human adult myocardial tissue and compared the angiogenic potential of rHuEpo to that of vascular endothelial growth factor (VEGF). They found that rHuEpo stimulated capillary outgrowth up to 220% compared to the nonstimulated physiological outgrowth. Epo therefore exhibited the same angiogenic potential as VEGF.
IGM is a new concept of microvascular growth
IGM constitutes an additional and/or alternative mechanism for endothelial sprouting and is not dependent on local endothelial cell proliferation or sprouting. Once accumulated, the endothelial cells can spread out and attenuate in order to cover the additional surface created by pillar formation. 23 According to IGM, the capillary network increases its complexity and vascular surface by inserting a multitude of transcapillary pillars through four consecutive steps: (1) creation of a zone of contact between opposite capillary walls; (2) reorganization of the Electron micrographs of CAM samples treated with rHuEPO. In (a) a vascular structure growing close to a large capillary vessel (asterisk). A poorly differentiated, highly arborized endothelial cell is recognizable (arrow) near a vascular tube (double arrow). In (b) the formation of a solid cord of endothelial cells 'sprouting' from the wall of a pre-existing capillary. The short vascular sprout presents a 'slit-like' lumen (arrow) and is closely surrounded by a fibroblast-like cell (double arrow). Bar: a, b ¼ 3 mm.
Figure 5
Electron micrographs of CAM samples treated with rHuEPO. In (a), the 'sprouting' shows a slit-like lumen (asterisk) sealed by junctional complexes (arrows). The 'sprouting' segment is enveloped by thin layers of the perivascular stromal cells (arrowheads). In (b), the lumen of a large vessel is subdivided into two parts (asterisks) by a process of 'intussusceptive' growth. There is a longitudinal in-growing proliferation of the stroma surrounding the capillary. The endothelial cells, forming the opposite walls of the capillary, come in contact with each other (arrows). Bar: a ¼ 2 mm; b 3 mm. intercellular junctions of the endothelium, with central perforation of the endothelial bilayer; (3) formation of an interstitial pillar core; and (4) subsequent invasion of the pillar by cytoplasmic extensions of myofibroblasts and pericytes, and by collagen fibrils. It is thought that the pillars then increase in diameter and become a capillary mesh.
IMG occurs in the normal condition during the development of the CAM vasculature
The CAM contains a relatively dense capillary network inserted between capillaries and veins. It comes in close contact with the shell and is responsible for the gas exchange between the environment and the embryo. 24 The CAM capillary network undergoes three phases of development characterized by very different growth processes. 18 In the early phase (days 5-7), sprouting of new capillaries represents the dominant angiogenic mechanism. Between days 8 and 12, the capillary network expands mainly by IGM. In the later stages (days 13 and 14), the CAM capillary network undergoes a simple expansion with not much increase in network complexity. The analysis of mitotic rates in the CAM fits well with the concept that early sprouting is followed by intussusception: mitotic rates were very high early in the CAM and decreased to very low levels after day 10. 17, 25 IMG is a peculiar angiogenic response of the CAM vasculature to rHuEpo
We have previously demonstrated that in the CAM assay, the angiogenic activity of rHuEpo is similar to that exerted by FGF-2 and that endothelial cells of the CAM expressed EpoR, which colocalized with factor VIII positivity. 13 Here, by means of an electron microscope, we show that after rHuEpo stimulation more frequently the generation of new blood vessels occurs following an IMG mechanism and is accomplished by a process of longitudinal segmentation of pre-existing blood vessels. This mechanism presents different aspects. Sometimes, we observe a process of progressive longitudinal invagination along the opposite sites of the vascular wall. The perivascular stroma penetrates deep into the lumen, pushing inside the endothelial lining and two distinct new vessels at last originate by the division of the primitive vessel. In other instances, a single endothelial cell connects the opposite walls of a pre-existing vessel, like a transluminal bridge, causing the splitting of the original vascular structure into two newly formed blood vessels. It worth noting that we have performed our experiments between days 8 and 12 of incubation, that is, when in the normal condition the capillary network expands mainly by IGM.
Moreover, this angiogenic response may be considered as a peculiar response to rHuEpo stimulation, because the coadministration of an Epo-blocking antibody abolished the angiogenic response induced by rHuEpo and because we have previously observed to a lower extent these pictures, expression of an IMG, when we used other angiogenic cytokines as angiogenic stimuli, such as FGF-2 and VEGF. [26] [27] [28] In conclusion, our findings suggest that IMG may be a characteristic response of the CAM vasculature to an angiogenic stimuli, such as rHuEpo. These data are of pivotal importance Figure 6 Electron micrographs of CAM samples treated with rHuEPO. In (a) a further stage of the 'intussusceptive' process is illustrated, leading to the formation of two vessel lumina. The perivascular stroma penetrates deep into the original lumen (arrow), pushing the endothelial lining inward and causing the formation of two distinct new vessels (asterisks). In (b) an endothelial cell connects the opposite sides of a capillary wall, forming a septum through the vessel lumen ('transluminal bridging'). Endothelial cells contain coated vesicles (arrowheads). Bar: a ¼ 3 mm; b ¼ 1.5 mm.
Figure 7
Electron micrograph of a CAM sample treated with rHuEPO. This figure depicts a well-differentiated vessel presenting a continuous endothelial cell lining (arrows), sealed by junctional complexes at the sites of cell-to-cell contact. Bar ¼ 2 mm.
not only for the understanding of the development of blood vessels in the CAM but also for the understanding of the mechanism of action of different angiogenic molecules in the CAM assay. 24 
